SCHEMBL2926544

SCHEMBL2926544

CCOC(=O)C=Cc1sccc1-c1c(-c2ccccc2)c(-c2ccccn2)c[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
MAPT P10636 2/20 0.35
CCNC P24863 3/20 0.34
CDK8 P49336 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ATM Q13315 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
BRD4 O60885 1/20 0.33
PTGS2 P35354 1/20 0.33
CDK19 Q9BWU1 1/20 0.33
SLC11A2 P49281 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
GSK3B P49841 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2923277 0.80 HTT (0.36) LMNAHTTMAPTSMN1; SMN2ATM
SCHEMBL1885104 0.74 GRIA1 (0.48) LMNAHTTMAPTCCNCCDK8
SCHEMBL3667468 0.73 PARP1 (0.45) LMNAHTTMAPTSMN1; SMN2ATM
SCHEMBL2926541 0.72 CCNC (0.35) LMNAHTTMAPTCCNCCDK8
SCHEMBL3665537 0.72 SMN1; SMN2 (0.35) HTTMAPTSMN1; SMN2ATMNPC1
SCHEMBL6679862 0.71 SMN1; SMN2 (0.44) LMNAHTTSMN1; SMN2ATMNPC1
SCHEMBL3667669 0.70 AXL (0.47) HTTGSK3B
SCHEMBL27521674 0.68 NPC1 (0.36) LMNAHTTMAPTCCNCCDK8
SCHEMBL2926370 0.68 SMN1; SMN2 (0.35) HTTMAPTSMN1; SMN2ATMNPC1
SCHEMBL3665777 0.68 CCNE1 (0.40) LMNAHTTSMN1; SMN2ATMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222296-A2 AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY Eisai R&D Management Co., Ltd. (JP) 2010-09-01 EP disclosed
EP-2164487-A1 AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR NEUROPATHIC PAIN Eisai R&D Management Co., Ltd. (JP) 2010-03-24 EP disclosed
EP-2164488-A1 AMPA RECEPTOR ANTAGONISTS AND ALDOSE REDUCTASE INHIBITORS FOR NEUROPATHIC PAIN Eisai R&D Management Co., Ltd. (JP) 2010-03-24 EP disclosed
EP-2164489-A2 COMBINATION OF AMPA RECEPTOR ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN Eisai R&D Management Co., Ltd. (JP) 2010-03-24 EP disclosed
EP-2131828-A2 AMPA AND NMDA RECEPTOR ANTAGONISTS FOR NEURODEGENERATIVE DISEASES Eisai R&D Management Co., Ltd. (JP) 2009-12-16 EP disclosed
WO-2009082038-A2 AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-07-02 WO disclosed
WO-2009011411-A1 AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR NEUROPATHIC PAIN EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-22 WO disclosed
WO-2009011410-A1 AMPA RECEPTOR ANTAGONISTS AND ALDOSE REDUCTASE INHIBITORS FOR NEUROPATHIC PAIN EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-22 WO disclosed
WO-2009011412-A2 COMBINATION OF AMPA RECEPTOR ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-22 WO disclosed
WO-2008111590-A2 AMPA AND NMDA RECEPTOR ANTAGONISTS FOR NEURODEGENERATIVE DISEASES EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-18 WO disclosed
EP-1871368-A2 DIHYDROPYRIDINE COMPOUNDS FOR NEURODEGENERATIVE DISEASES AND DEMENTIA Eisai Co., Ltd. (JP) 2008-01-02 EP disclosed
WO-2006107859-A2 DIHYDROPYRIDINE COMPOUNDS FOR NEURODEGENERATIVE DISEASES AND DEMENTIA EISAI CO., LTD. (JP) 2006-10-12 WO disclosed